ArticleEuropean journal of medical research2025
The association of metabolic syndrome with aortic aneurysm: a two-sample Mendelian randomization study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMetabolic syndrome (MetS) has been proved to be associated with cardiovascular disease, and recent observational studies have revealed the association between MetS and its components and aortic aneurysm (AA), but the causal relationship still uncertain. The study aimed to explore the causal effect of MetS on AA using Mendelian randomization (MR) analysis.
methodsSingle nucleotide polymorphisms (SNP) of MetS and its components were extracted from publicly available genome-wide association study (GWAS) database. Inverse variance weighting (IVW), weighted median method, simple mode method, weighted mode method, and MR-Egger regression were used to evaluate causality. Sensitivity analysis, heterogeneity test, and pleiotropy test were done so as to ensure the stability of the analyzed results.
resultsIVW showed that genetically predicted MetS had a significantly positive association with the risk of AA (OR: 1.308; 95% CI 1.175-1.456). In exploring the causal relationship between the components of MetS and AA, body mass index (BMI) (OR: 1.322; 95% CI 1.132-1.543), waist circumstance (WC) (OR: 1.282; 95% CI 1.055-1.558), triglycerides (TG) (OR: 1.436; 95% CI 1.253-1.646), systolic blood pressure (SBP) (OR: 1.023; 95% CI 1.014-1.033), and diastolic blood pressure (DBP) (OR: 1.086; 95% CI 1.069-1.103) could increase the risk of AA. However, high density lipoprotein cholesterol (HDL-C) (OR: 0.722; 95% CI 0.638-0.818), fasting blood glucose (OR: 0.683; 95% CI 0.488-0.957) and type 2 diabetes (T2DM) (OR: 0.904; 95% CI 0.831-0.983) were negative association with the risk of AA.
conclusionsThe present study strengthened the evidence for a causal association between MetS and the risk of AA and revealed that MetS and its individual components, excluding elevated blood glucose and T2DM, increased the risk of AA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.